(-)-anisomycin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein] CTD PMID:23246481 (-)-anisomycin increases phosphorylation ISO RGD:619568 6480464 Anisomycin results in increased phosphorylation of CAV1 protein CTD PMID:23246481 (1->4)-beta-D-glucan multiple interactions ISO RGD:1553438 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CAV1 mRNA CTD PMID:36331819 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:619568 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein CTD PMID:19706615 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:619568 6480464 2 more ... CTD PMID:19706615 1,2-dimethylhydrazine decreases expression ISO RGD:1553438 6480464 1, 2-Dimethylhydrazine results in decreased expression of CAV1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1553438 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAV1 mRNA CTD PMID:22206623 13-HPODE increases expression ISO RGD:619568 6480464 13-hydroperoxy-9, 11-octadecadienoic acid results in increased expression of CAV1 mRNA CTD PMID:27257344 17beta-estradiol multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA, Estradiol inhibits the reaction [Fulvestrant results in decreased expression of CAV1 mRNA] CTD PMID:19619570 , PMID:31646340 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CAV1 mRNA CTD PMID:35700937 17beta-estradiol increases expression ISO RGD:619568 6480464 Estradiol results in increased expression of CAV1 mRNA CTD PMID:31646340 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:27174447 17beta-estradiol increases phosphorylation ISO RGD:619568 6480464 Estradiol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 17beta-estradiol decreases expression ISO RGD:619568 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553438 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV1 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553438 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CAV1 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of CAV mRNA CTD PMID:19643169 2-methoxyethanol affects expression EXP 6480464 methyl cellosolve affects the expression of CAV mRNA CTD PMID:19643169 22-Hydroxycholesterol increases expression ISO RGD:619568 6480464 22-hydroxycholesterol results in increased expression of CAV1 mRNA CTD PMID:15314095 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [3 more ... CTD PMID:19265715 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:619568 6480464 3 more ... CTD PMID:24709675 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 3 more ... CTD PMID:18786521 , PMID:20406653 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:1553438 6480464 3 more ... CTD PMID:18786521 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1553438 6480464 tetrabromobisphenol A results in decreased expression of CAV1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA CTD PMID:16054899 3-Nitrobenzanthrone increases expression ISO RGD:619568 6480464 3-nitrobenzanthrone results in increased expression of CAV1 mRNA CTD PMID:34036453 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CAV1 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1553438 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CAV1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:619568 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CAV1 protein CTD PMID:31945527 4,4'-sulfonyldiphenol decreases methylation ISO RGD:619568 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of CAV1 gene CTD PMID:31601247 5-aza-2'-deoxycytidine increases expression ISO RGD:619568 6480464 Decitabine results in increased expression of CAV1 mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine multiple interactions ISO RGD:619568 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 5-fluorouracil affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil increases expression ISO RGD:619568 6480464 Fluorouracil results in increased expression of CAV1 mRNA CTD PMID:24737281 5-fluorouracil decreases expression ISO RGD:619568 6480464 Fluorouracil results in decreased expression of CAV1 protein CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CAV1 mRNA CTD PMID:24780913 , PMID:30047161 acetylcholine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine] CTD PMID:18178722 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of CAV1 mRNA CTD PMID:12800193 acrolein multiple interactions ISO RGD:619568 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CAV1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CAV1 mRNA CTD PMID:32699268 actinomycin D multiple interactions ISO RGD:619568 6480464 Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 aflatoxin B1 increases expression ISO RGD:619568 6480464 Aflatoxin B1 results in increased expression of CAV1 mRNA CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 , PMID:31655124 aldehydo-D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 all-trans-retinoic acid decreases expression ISO RGD:619568 6480464 Tretinoin results in decreased expression of CAV1 mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO RGD:619568 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CAV1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CAV1 mRNA CTD PMID:32699268 aminoguanidine decreases expression ISO RGD:619568 6480464 pimagedine results in decreased expression of CAV1 protein CTD PMID:19706615 amitrole increases expression EXP 6480464 Amitrole results in increased expression of CAV1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CAV1 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of CAV1 protein CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of CAV1 mRNA CTD PMID:30779732 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of CAV1 mRNA CTD PMID:22352330 antirheumatic drug increases expression ISO RGD:619568 6480464 Antirheumatic Agents results in increased expression of CAV1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1553438 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CAV1 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:619568 6480464 arsenite inhibits the reaction [Fulvestrant results in decreased expression of CAV1 mRNA] more ... CTD PMID:12640124 more ... arsenite(3-) decreases expression ISO RGD:619568 6480464 arsenite results in decreased expression of CAV1 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:1553438 6480464 tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein] CTD PMID:14511371 arsenite(3-) increases phosphorylation ISO RGD:1553438 6480464 arsenite results in increased phosphorylation of CAV1 protein CTD PMID:14511371 arsenous acid decreases expression ISO RGD:619568 6480464 Arsenic Trioxide results in decreased expression of CAV1 mRNA, Arsenic Trioxide results in decreased expression of CAV1 protein CTD PMID:15725085 more ... arsenous acid increases expression ISO RGD:619568 6480464 Arsenic Trioxide results in increased expression of CAV1 mRNA, Arsenic Trioxide results in increased expression of CAV1 protein CTD PMID:17512576 , PMID:22521957 atrazine increases expression ISO RGD:619568 6480464 Atrazine results in increased expression of CAV1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in increased expression of CAV1 protein CTD PMID:26657896 benzo[a]pyrene increases methylation ISO RGD:619568 6480464 Benzo(a)pyrene results in increased methylation of CAV1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in increased expression of CAV1 mRNA CTD PMID:22228805 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:619568 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 beta-carotene decreases expression ISO RGD:619568 6480464 beta Carotene results in decreased expression of CAV1 protein CTD PMID:26733226 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:619568 6480464 Diethylhexyl Phthalate results in increased expression of CAV1 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CAV1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:619568 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of CAV1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:619568 6480464 bisphenol A results in increased expression of CAV1 mRNA, bisphenol A results in increased expression of CAV1 protein CTD PMID:32028606 , PMID:34186270 bisphenol A affects methylation ISO RGD:619568 6480464 bisphenol A affects the methylation of CAV1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1553438 6480464 bisphenol A results in increased expression of CAV1 mRNA CTD PMID:30951980 bisphenol A multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CAV1 mRNA more ... CTD PMID:28067316 , PMID:35700937 bisphenol A decreases acetylation EXP 6480464 bisphenol A results in decreased acetylation of CAV1 protein CTD PMID:28067316 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CAV1 mRNA, bisphenol A results in decreased expression of CAV1 protein CTD PMID:27174447 , PMID:35700937 Bisphenol A diglycidyl ether multiple interactions ISO RGD:619568 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein] CTD PMID:16806087 Bisphenol B increases expression ISO RGD:619568 6480464 bisphenol B results in increased expression of CAV1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1553438 6480464 bisphenol F results in increased expression of CAV1 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:619568 6480464 bisphenol F results in increased expression of CAV1 protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of CAV1 protein CTD PMID:25933445 butan-1-ol multiple interactions ISO RGD:619568 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CAV1 mRNA CTD PMID:29432896 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of CAV1 mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:1553438 6480464 Cadmium promotes the reaction [HMOX1 protein binds to CAV1 protein] CTD PMID:14658758 cadmium atom multiple interactions ISO RGD:619568 6480464 Cadmium inhibits the reaction [Fulvestrant results in decreased expression of CAV1 mRNA], Fulvestrant inhibits the reaction [Cadmium results in decreased expression of CAV1 mRNA] CTD PMID:31646340 cadmium atom decreases expression ISO RGD:619568 6480464 Cadmium results in decreased expression of CAV1 mRNA CTD PMID:31646340 cadmium dichloride increases expression ISO RGD:619568 6480464 Cadmium Chloride results in increased expression of CAV1 mRNA CTD PMID:26472689 cadmium nitrate decreases expression ISO RGD:619568 6480464 cadmium nitrate results in decreased expression of CAV1 protein CTD PMID:19061949 caffeine increases expression ISO RGD:619568 6480464 Caffeine results in increased expression of CAV1 protein CTD PMID:31195006 calcitriol multiple interactions ISO RGD:619568 6480464 Calcitriol results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 calcium atom affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 calcium(0) affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 camptothecin decreases methylation ISO RGD:619568 6480464 Camptothecin results in decreased methylation of CAV1 gene CTD PMID:30720231 captan decreases expression ISO RGD:1553438 6480464 Captan results in decreased expression of CAV1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:619568 6480464 Carbamazepine affects the expression of CAV1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1553438 6480464 Nanotubes, Carbon analog results in decreased expression of CAV1 mRNA CTD PMID:21624382 , PMID:25554681 carboxy-PTIO decreases expression ISO RGD:619568 6480464 1 more ... CTD PMID:19706615 celecoxib increases expression ISO RGD:619568 6480464 Celecoxib results in increased expression of CAV1 protein CTD PMID:18848576 CGP 52608 multiple interactions ISO RGD:619568 6480464 CGP 52608 promotes the reaction [RORA protein binds to CAV1 gene] CTD PMID:28238834 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CAV1 mRNA CTD PMID:30744511 chloropicrin affects expression ISO RGD:619568 6480464 chloropicrin affects the expression of CAV1 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:619568 6480464 chloropicrin results in decreased expression of CAV1 mRNA CTD PMID:28476498 cholesterol increases transport ISO RGD:619568 6480464 CAV1 protein results in increased transport of Cholesterol CTD PMID:12640124 cholesterol multiple interactions ISO RGD:1553438 6480464 CAV1 protein affects the reaction [Cholesterol affects the localization of APOE protein] CTD PMID:21169230 cholesterol multiple interactions EXP 6480464 Cholesterol promotes the reaction [APOE protein binds to CAV1 protein] CTD PMID:21169230 chromium atom multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein], [Niacin co-treated with Chromium] results in decreased expression of CAV1 protein CTD PMID:19027847 chrysene decreases expression ISO RGD:1553438 6480464 chrysene results in decreased expression of CAV1 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 ciprofloxacin increases expression ISO RGD:619568 6480464 Ciprofloxacin results in increased expression of CAV1 protein CTD PMID:26947806 cisplatin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin increases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in increased susceptibility to Cisplatin, CAV1 protein results in increased susceptibility to Cisplatin CTD PMID:35622184 cisplatin multiple interactions ISO RGD:619568 6480464 [ACE2 protein promotes the reaction [CAV1 protein results in increased expression of CYP3A4 protein]] which results in decreased susceptibility to Cisplatin more ... CTD PMID:30871063 , PMID:35622184 cisplatin increases expression ISO RGD:619568 6480464 Cisplatin results in increased expression of CAV1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CAV1 mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:1553438 6480464 Cisplatin affects the expression of CAV1 mRNA CTD PMID:21151649 clofibrate affects expression ISO RGD:619568 6480464 Clofibrate affects the expression of CAV1 protein CTD PMID:17961437 cobalt dichloride decreases expression ISO RGD:619568 6480464 cobaltous chloride results in decreased expression of CAV1 mRNA CTD PMID:19320972 coumestrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:619568 6480464 Coumestrol results in increased expression of CAV1 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1553438 6480464 Asbestos, Crocidolite results in decreased expression of CAV1 mRNA CTD PMID:29279043 cumene decreases expression ISO RGD:1553438 6480464 cumene results in decreased expression of CAV1 mRNA CTD PMID:18648096 cycloheximide multiple interactions ISO RGD:619568 6480464 Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 cyclosporin A decreases expression ISO RGD:619568 6480464 Cyclosporine results in decreased expression of CAV1 mRNA CTD PMID:20106945 , PMID:27989131 cylindrospermopsin increases expression ISO RGD:619568 6480464 cylindrospermopsin results in increased expression of CAV1 mRNA CTD PMID:24921660 cyproconazole decreases expression ISO RGD:619568 6480464 cyproconazole results in decreased expression of CAV1 mRNA CTD PMID:26238599 D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 , PMID:31655124 depsipeptide multiple interactions ISO RGD:619568 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 desferrioxamine B increases expression ISO RGD:619568 6480464 Deferoxamine results in increased expression of CAV1 protein CTD PMID:16927372 dexamethasone multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA more ... CTD PMID:14984747 , PMID:16054899 dexamethasone multiple interactions ISO RGD:619568 6480464 [Dexamethasone results in increased expression of CAV1 protein] which results in decreased susceptibility to VEGFA protein CTD PMID:23426970 dexamethasone increases expression ISO RGD:619568 6480464 Dexamethasone results in increased expression of CAV1 mRNA, Dexamethasone results in increased expression of CAV1 protein CTD PMID:23426970 , PMID:25047013 diallyl disulfide multiple interactions ISO RGD:619568 6480464 diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diallyl trisulfide multiple interactions ISO RGD:619568 6480464 diallyl trisulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diarsenic trioxide increases expression ISO RGD:619568 6480464 Arsenic Trioxide results in increased expression of CAV1 mRNA, Arsenic Trioxide results in increased expression of CAV1 protein CTD PMID:17512576 , PMID:22521957 diarsenic trioxide decreases expression ISO RGD:619568 6480464 Arsenic Trioxide results in decreased expression of CAV1 mRNA, Arsenic Trioxide results in decreased expression of CAV1 protein CTD PMID:15725085 more ... dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CAV1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CAV1 mRNA CTD PMID:21658437 diethylstilbestrol increases expression ISO RGD:619568 6480464 Diethylstilbestrol results in increased expression of CAV1 mRNA CTD PMID:36621641 dioxygen multiple interactions ISO RGD:1553438 6480464 [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB mRNA more ... CTD PMID:24835767 dioxygen increases expression ISO RGD:619568 6480464 Oxygen deficiency results in increased expression of CAV1 mRNA, Oxygen deficiency results in increased expression of CAV1 protein CTD PMID:18717816 dioxygen multiple interactions ISO RGD:619568 6480464 [Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3 more ... CTD PMID:18717816 dioxygen multiple interactions EXP 6480464 [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA more ... CTD PMID:16698853 , PMID:24835767 dioxygen increases response to substance ISO RGD:1553438 6480464 CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency CTD PMID:24835767 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CAV1 mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO RGD:1553438 6480464 Doxorubicin results in increased expression of CAV1 mRNA CTD PMID:22008532 equol multiple interactions ISO RGD:619568 6480464 Equol inhibits the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:16840783 ethanol increases expression ISO RGD:619568 6480464 Ethanol results in increased expression of CAV1 mRNA CTD PMID:15963989 ethanol multiple interactions ISO RGD:1553438 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CAV1 mRNA CTD PMID:30517762 ethyl methanesulfonate decreases expression ISO RGD:619568 6480464 Ethyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:619568 6480464 Fenofibrate results in increased expression of CAV1 mRNA CTD PMID:15314095 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CAV1 mRNA CTD PMID:34044035 folic acid increases expression ISO RGD:1553438 6480464 Folic Acid results in increased expression of CAV1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1553438 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAV1 mRNA CTD PMID:22206623 folpet decreases expression ISO RGD:1553438 6480464 folpet results in decreased expression of CAV1 mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:619568 6480464 Formaldehyde results in decreased expression of CAV1 mRNA CTD PMID:23649840 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA], fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein] CTD PMID:17091190 fulvestrant multiple interactions ISO RGD:619568 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of CAV1 gene more ... CTD PMID:31601247 , PMID:31646340 fulvestrant decreases expression ISO RGD:619568 6480464 Fulvestrant results in decreased expression of CAV1 mRNA CTD PMID:31646340 furan increases expression EXP 6480464 furan results in increased expression of CAV1 mRNA CTD PMID:27387713 gefitinib increases expression ISO RGD:619568 6480464 gefitinib results in increased expression of CAV1 mRNA, gefitinib results in increased expression of CAV1 protein CTD PMID:19288272 genistein decreases expression ISO RGD:619568 6480464 Genistein results in decreased expression of CAV1 mRNA CTD PMID:22228119 geranylgeraniol multiple interactions ISO RGD:619568 6480464 geranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 , PMID:31655124 Glutathione ethyl ester multiple interactions ISO RGD:619568 6480464 S-ethyl glutathione inhibits the reaction [2 more ... CTD PMID:35349355 glycidyl methacrylate increases expression ISO RGD:619568 6480464 glycidyl methacrylate results in increased expression of CAV1 protein CTD PMID:36641056 hexadecanoic acid decreases phosphorylation ISO RGD:619568 6480464 Palmitic Acid results in decreased phosphorylation of CAV1 protein CTD PMID:28073184 hydrogen peroxide multiple interactions ISO RGD:619568 6480464 Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein] more ... CTD PMID:12640124 more ... hydrogen peroxide increases phosphorylation ISO RGD:619568 6480464 Hydrogen Peroxide results in increased phosphorylation of CAV1 protein CTD PMID:23246481 , PMID:25512378 hydrogen peroxide increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:12640124 hydrogen peroxide increases expression ISO RGD:1553438 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA, Hydrogen Peroxide results in increased expression of CAV1 protein CTD PMID:12134086 , PMID:17108117 hydrogen peroxide multiple interactions ISO RGD:1553438 6480464 [Hydrogen Peroxide co-treated with CAV1 protein] results in increased expression of CDKN1A protein more ... CTD PMID:12134086 more ... hydrogen peroxide increases expression ISO RGD:619568 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA, Hydrogen Peroxide results in increased expression of CAV1 protein CTD PMID:18385095 inulin multiple interactions ISO RGD:1553438 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CAV1 mRNA CTD PMID:36331819 iron atom affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(0) affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) affects localization EXP 6480464 ferrous sulfate affects the localization of CAV1 protein CTD PMID:17172471 isoprenaline multiple interactions ISO RGD:1553438 6480464 CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] CTD PMID:18820136 ivermectin decreases expression ISO RGD:619568 6480464 Ivermectin results in decreased expression of CAV1 protein CTD PMID:32959892 ketoconazole increases expression ISO RGD:619568 6480464 Ketoconazole results in increased expression of CAV1 mRNA CTD PMID:36621641 L-ascorbic acid multiple interactions ISO RGD:619568 6480464 Ascorbic Acid inhibits the reaction [2 more ... CTD PMID:35349355 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CAV1 mRNA CTD PMID:11578147 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CAV1 mRNA CTD PMID:22641619 lipopolysaccharide multiple interactions ISO RGD:619568 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CAV1 mRNA more ... CTD PMID:24835767 more ... lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lipopolysaccharide multiple interactions EXP 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:26357463 lipopolysaccharide affects expression ISO RGD:1553438 6480464 Lipopolysaccharides affects the expression of CAV1 mRNA, Lipopolysaccharides affects the expression of CAV1 protein CTD PMID:10948129 lipopolysaccharide multiple interactions ISO RGD:1553438 6480464 CAV1 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA], CAV1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA] CTD PMID:24835767 lipopolysaccharide increases expression ISO RGD:619568 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lithocholic acid multiple interactions ISO RGD:619568 6480464 Lithocholic Acid results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 lysophosphatidylcholine multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] more ... CTD PMID:27257344 lysophosphatidylcholine increases expression ISO RGD:619568 6480464 Lysophosphatidylcholines results in increased expression of CAV1 mRNA, Lysophosphatidylcholines results in increased expression of CAV1 protein CTD PMID:27257344 manganese atom decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA, Manganese results in decreased expression of CAV1 protein CTD PMID:23499988 , PMID:23597857 manganese(0) decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA, Manganese results in decreased expression of CAV1 protein CTD PMID:23499988 , PMID:23597857 mercury dibromide increases expression ISO RGD:619568 6480464 mercuric bromide results in increased expression of CAV1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CAV1 mRNA CTD PMID:32035215 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CAV1 mRNA CTD PMID:30047161 methotrexate decreases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in decreased susceptibility to Methotrexate CTD PMID:18694510 methotrexate increases expression ISO RGD:619568 6480464 Methotrexate results in increased expression of CAV1 mRNA CTD PMID:21678067 methotrexate affects response to substance ISO RGD:619568 6480464 CAV1 mRNA affects the susceptibility to Methotrexate CTD PMID:22753658 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of CAV1 gene CTD PMID:23303685 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form] CTD PMID:26357463 methyl beta-cyclodextrin multiple interactions ISO RGD:1553438 6480464 methyl-beta-cyclodextrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein] CTD PMID:20060843 methyl methanesulfonate decreases expression ISO RGD:619568 6480464 Methyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 methylisothiazolinone decreases expression ISO RGD:619568 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of CAV1 protein CTD PMID:29110394 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CAV1 mRNA CTD PMID:30744511 mifepristone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 miquelianin multiple interactions ISO RGD:619568 6480464 quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CAV1 mRNA, Monocrotaline results in decreased expression of CAV1 protein CTD PMID:24835767 , PMID:25275723 monocrotaline multiple interactions EXP 6480464 NCP-2454 inhibits the reaction [Monocrotaline results in decreased expression of CAV1 protein] CTD PMID:25275723 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:619568 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein] CTD PMID:18717816 N-acetyl-L-cysteine decreases expression ISO RGD:619568 6480464 Acetylcysteine results in decreased expression of CAV1 CTD PMID:21148404 N-acetyl-L-cysteine multiple interactions ISO RGD:619568 6480464 Acetylcysteine inhibits the reaction [2 more ... CTD PMID:18507034 more ... N-acetylsphingosine multiple interactions ISO RGD:619568 6480464 N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein] CTD PMID:12640124 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1553438 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CAV1 mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:619568 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CAV1 protein CTD PMID:19706615 N-methyl-D-aspartic acid multiple interactions ISO RGD:619568 6480464 CAV1 protein affects the reaction [N-Methylaspartate results in decreased expression of TJP1 mRNA] more ... CTD PMID:35257817 N-methyl-D-aspartic acid increases phosphorylation ISO RGD:619568 6480464 N-Methylaspartate results in increased phosphorylation of CAV1 protein CTD PMID:35257817 N-nitrosodiethylamine increases expression ISO RGD:619568 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:1553438 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CAV1 mRNA, Dimethylnitrosamine results in increased expression of CAV1 protein CTD PMID:18364076 , PMID:25380136 N-nitrosodimethylamine multiple interactions EXP 6480464 Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] CTD PMID:18364076 nicotinic acid multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein], [Niacin co-treated with Chromium] results in decreased expression of CAV1 protein CTD PMID:19027847 nimesulide increases expression ISO RGD:619568 6480464 nimesulide results in increased expression of CAV1 protein CTD PMID:18848576 nitric oxide multiple interactions ISO RGD:619568 6480464 [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide more ... CTD PMID:18296501 , PMID:19706615 nitric oxide increases expression ISO RGD:619568 6480464 Nitric Oxide results in increased expression of CAV1 protein CTD PMID:19706615 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CAV1 mRNA, nitrofen results in decreased expression of CAV1 protein CTD PMID:25078423 nitroprusside multiple interactions ISO RGD:619568 6480464 Nitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein, Nitroprusside results in increased metabolism of and results in increased stability of CAV1 protein CTD PMID:19706615 nitroprusside increases expression ISO RGD:619568 6480464 Nitroprusside results in increased expression of CAV1 protein CTD PMID:19706615 NS-398 decreases expression ISO RGD:619568 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CAV1 protein CTD PMID:18848576 nystatin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] CTD PMID:17876056 octanoic acid multiple interactions ISO RGD:1553438 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein, [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] CTD PMID:14984747 ouabain decreases expression ISO RGD:619568 6480464 Ouabain results in decreased expression of CAV1 mRNA CTD PMID:28795476 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CAV1 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1553438 6480464 Ozone results in decreased expression of CAV1 mRNA, Ozone results in decreased expression of CAV1 protein CTD PMID:12763052 , PMID:18207479 ozone multiple interactions ISO RGD:619568 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CAV1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1553438 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CAV1 mRNA, TNF protein affects the reaction [Ozone results in decreased expression of CAV1 protein] CTD PMID:18207479 , PMID:34911549 p-menthan-3-ol increases expression ISO RGD:619568 6480464 Menthol results in increased expression of CAV1 mRNA CTD PMID:26760959 paclitaxel increases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in increased susceptibility to Paclitaxel CTD PMID:16322897 paracetamol decreases expression ISO RGD:1553438 6480464 Acetaminophen results in decreased expression of CAV1 protein CTD PMID:20100502 paracetamol increases response to substance ISO RGD:1553438 6480464 CAV1 results in increased susceptibility to Acetaminophen CTD PMID:20100502 paracetamol decreases expression ISO RGD:619568 6480464 Acetaminophen results in decreased expression of CAV1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein] more ... CTD PMID:20100502 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CAV1 mRNA, Paraquat results in increased expression of CAV1 protein CTD PMID:26813466 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1553438 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CAV1 mRNA more ... CTD PMID:36331819 phenethyl isothiocyanate decreases expression ISO RGD:619568 6480464 phenethyl isothiocyanate results in decreased expression of CAV1 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1553438 6480464 Phenobarbital affects the expression of CAV1 mRNA CTD PMID:23091169 phenylephrine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine] CTD PMID:18178722 phenylmercury acetate increases expression ISO RGD:619568 6480464 Phenylmercuric Acetate results in increased expression of CAV1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 pioglitazone affects expression ISO RGD:619568 6480464 pioglitazone affects the expression of CAV1 protein CTD PMID:17961437 pirinixic acid multiple interactions ISO RGD:1553438 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAV1 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:619568 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV1 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:619568 6480464 Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of CAV1 mRNA CTD PMID:26923065 potassium chloride multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride] CTD PMID:18178722 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CAV1 mRNA CTD PMID:30047161 progesterone increases expression ISO RGD:619568 6480464 Progesterone results in increased expression of CAV1 mRNA CTD PMID:15674352 progesterone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 quartz decreases expression ISO RGD:1553438 6480464 Quartz results in decreased expression of CAV1 mRNA, Quartz results in decreased expression of CAV1 protein CTD PMID:36053221 quartz multiple interactions ISO RGD:1553438 6480464 CAV1 protein modified form inhibits the reaction [Quartz affects the localization of YAP1 protein] more ... CTD PMID:36053221 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein] CTD PMID:26357463 quercetin multiple interactions ISO RGD:1553438 6480464 Quercetin inhibits the reaction [[lipopolysaccharide more ... CTD PMID:12134086 more ... quercetin decreases expression ISO RGD:1553438 6480464 Quercetin results in decreased expression of CAV1 protein CTD PMID:12134086 quercetin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] more ... CTD PMID:17876056 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of CAV1 protein CTD PMID:16331104 raloxifene multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA], fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein] CTD PMID:17091190 raloxifene affects expression ISO RGD:619568 6480464 Raloxifene Hydrochloride affects the expression of CAV1 mRNA CTD PMID:14699072 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of CAV1 mRNA, Raloxifene Hydrochloride results in increased expression of CAV1 protein CTD PMID:17091190 reactive oxygen species multiple interactions ISO RGD:1553438 6480464 Reactive Oxygen Species promotes the reaction [CAVIN1 protein binds to CAV1 protein] CTD PMID:21705337 rebaudioside A decreases expression ISO RGD:619568 6480464 rebaudioside A results in decreased expression of CAV1 mRNA CTD PMID:31655124 resveratrol affects transport ISO RGD:619568 6480464 CAV1 protein affects the transport of resveratrol CTD PMID:19321006 resveratrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA more ... CTD PMID:18296501 , PMID:19167446 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CAV1 protein CTD PMID:18266981 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]], Resveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein] CTD PMID:18266981 resveratrol increases phosphorylation ISO RGD:619568 6480464 resveratrol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 resveratrol increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to resveratrol CTD PMID:19321006 resveratrol increases expression ISO RGD:619568 6480464 resveratrol results in increased expression of CAV1 protein CTD PMID:19321006 rimonabant affects expression ISO RGD:1553438 6480464 Rimonabant affects the expression of CAV1 mRNA CTD PMID:19030233 rimonabant multiple interactions ISO RGD:1553438 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CAV1 mRNA] CTD PMID:19030233 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:619568 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of CAV1 mRNA CTD PMID:33725128 , PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:619568 6480464 [S-(1 more ... CTD PMID:35811015 saracatinib multiple interactions EXP 6480464 saracatinib inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein] CTD PMID:26357463 SB 203580 multiple interactions ISO RGD:619568 6480464 SB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]], SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein] CTD PMID:17108117 , PMID:25512378 SB 203580 multiple interactions ISO RGD:1553438 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] more ... CTD PMID:14984747 more ... SB 431542 multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO RGD:1553438 6480464 senecionine results in decreased expression of CAV1 protein CTD PMID:35357534 silicon dioxide increases expression ISO RGD:619568 6480464 Silicon Dioxide analog results in increased expression of CAV1 mRNA, Silicon Dioxide results in increased expression of CAV1 mRNA CTD PMID:25895662 , PMID:28425640 silicon dioxide decreases expression ISO RGD:1553438 6480464 Silicon Dioxide results in decreased expression of CAV1 mRNA CTD PMID:29203145 simvastatin multiple interactions ISO RGD:619568 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein] CTD PMID:16698853 simvastatin decreases expression ISO RGD:1553438 6480464 Simvastatin results in decreased expression of CAV1 protein CTD PMID:18224302 simvastatin multiple interactions ISO RGD:1553438 6480464 Simvastatin promotes the reaction [[APOA4 protein co-treated with CBS protein] affects the expression of CAV1 protein] CTD PMID:18224302 sodium arsenite multiple interactions ISO RGD:619568 6480464 AKT1 mutant form inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite], wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite] CTD PMID:12640124 sodium arsenite decreases expression ISO RGD:619568 6480464 sodium arsenite results in decreased expression of CAV1 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:19072884 sodium arsenite increases expression ISO RGD:1553438 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:17123562 , PMID:29044176 sodium arsenite decreases expression ISO RGD:1553438 6480464 sodium arsenite results in decreased expression of CAV1 mRNA CTD PMID:16014739 sodium arsenite increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to sodium arsenite CTD PMID:12640124 Soman increases expression EXP 6480464 Soman results in increased expression of CAV mRNA, Soman results in increased expression of CAV1 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]] more ... CTD PMID:18266981 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CAV1 protein CTD PMID:18266981 sulfasalazine multiple interactions ISO RGD:1553438 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA], [Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA CTD PMID:19015640 tamoxifen affects expression ISO RGD:619568 6480464 Tamoxifen affects the expression of CAV1 mRNA CTD PMID:14699072 tamoxifen increases expression ISO RGD:619568 6480464 Tamoxifen results in increased expression of CAV1 protein CTD PMID:19288272 taurocholic acid increases secretion ISO RGD:619568 6480464 CAV1 protein results in increased secretion of Taurocholic Acid CTD PMID:14647059 tert-butyl hydroperoxide increases expression ISO RGD:619568 6480464 tert-Butylhydroperoxide results in increased expression of CAV1 mRNA CTD PMID:15963989 testosterone multiple interactions ISO RGD:619568 6480464 [FSHB protein co-treated with Testosterone] results in decreased expression of CAV1 mRNA CTD PMID:18535249 tetrachloromethane increases expression ISO RGD:1553438 6480464 Carbon Tetrachloride results in increased expression of CAV1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1553438 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CAV1 mRNA CTD PMID:30517762 tetraphene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 theophylline increases expression ISO RGD:619568 6480464 Theophylline results in increased expression of CAV1 mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CAV1 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1553438 6480464 titanium dioxide results in decreased expression of CAV1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression ISO RGD:619568 6480464 titanium dioxide results in increased expression of CAV1 protein CTD PMID:30910687 tolfenamic acid multiple interactions ISO RGD:619568 6480464 CAV1 protein affects the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein] CTD PMID:31381904 toluene 2,4-diisocyanate multiple interactions ISO RGD:619568 6480464 AG 1879 inhibits the reaction [Toluene 2 more ... CTD PMID:29940203 , PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:1553438 6480464 FPS-ZM1 inhibits the reaction [Toluene 2, 4-Diisocyanate results in increased phosphorylation of CAV1 protein] CTD PMID:30261222 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:619568 6480464 Toluene 2, 4-Diisocyanate analog results in increased phosphorylation of CAV1 protein CTD PMID:30261222 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:1553438 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of CAV1 protein CTD PMID:30261222 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 tremolite asbestos decreases expression ISO RGD:1553438 6480464 tremolite results in decreased expression of CAV1 mRNA CTD PMID:29279043 triadimefon decreases expression ISO RGD:619568 6480464 triadimefon analog results in decreased expression of CAV1 mRNA, triadimefon results in decreased expression of CAV1 mRNA CTD PMID:26238599 , PMID:26705709 trichostatin A increases expression ISO RGD:619568 6480464 trichostatin A results in increased expression of CAV1 mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:619568 6480464 Triclosan results in increased expression of CAV1 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1553438 6480464 trimellitic anhydride results in decreased expression of CAV1 mRNA CTD PMID:19042947 Triptolide increases expression EXP 6480464 triptolide results in increased expression of CAV1 protein CTD PMID:32519852 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CAV1 mRNA CTD PMID:21515302 trovafloxacin increases expression ISO RGD:1553438 6480464 trovafloxacin results in increased expression of CAV1 mRNA CTD PMID:35537566 tyrphostin AG 1478 multiple interactions ISO RGD:619568 6480464 RTKI cpd inhibits the reaction [Rosiglitazone results in increased expression of CAV1] CTD PMID:18507034 valproic acid decreases expression ISO RGD:619568 6480464 Valproic Acid results in decreased expression of CAV1 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid increases methylation ISO RGD:619568 6480464 Valproic Acid results in increased methylation of CAV1 gene CTD PMID:29501571 valproic acid multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:619568 6480464 Valproic Acid results in increased expression of CAV1 mRNA, Valproic Acid results in increased expression of CAV1 protein CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:619568 6480464 Valproic Acid results in decreased methylation of CAV1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:619568 6480464 Valproic Acid affects the expression of CAV1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CAV mRNA CTD PMID:19015723 vitamin E multiple interactions ISO RGD:1553438 6480464 Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] CTD PMID:12134086 vitamin E multiple interactions ISO RGD:619568 6480464 Vitamin E inhibits the reaction [2 more ... CTD PMID:35349355 vorinostat increases expression ISO RGD:619568 6480464 vorinostat results in increased expression of CAV1 mRNA CTD PMID:26272509 wogonin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein], wogonin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein] CTD PMID:23246481 wortmannin multiple interactions ISO RGD:619568 6480464 wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide], wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite] CTD PMID:12640124